Subscribe

Niels van de Donk, MD, PhD

Articles by Niels van de Donk, MD, PhD

Latest Updated Articles

Trending on CGTlive®

Around the Helix: Cell and Gene Therapy Company Updates – November 19, 2025

Bladder Cancer Gene Therapy Detalimogene Effects 62% CRR at 6 Months Posttreatment

Where are the Biggest Bottlenecks in Cell and Gene Therapy?

Stephen M. Ansell, MD, PhD, on Integrating Cell Therapy into Clinical Practice in Oncology

© 2025 MJH Life Sciences^®

All rights reserved.